Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat rare and orphan autoimmune and inflammatory diseases. Its lead drug candidate is Coversin, a second-generation C5 complement inhibitor that is in Phase Ib clinical trial for the treatment of autoimmune and inflammatory diseases, including paroxysmal nocturnal hemoglobinuria, guillain barre syndrome, and atypical hemolytic uremic syndrome. The company is based in New York, New York. Akari Therapeutics, Plc operates as a subsidiary of RPC Pharma Limited.
I ended up taking 1000 shares of $AKTX for 1450 profit and ending the Day up $1710.00 Not a bad way to end the week! Whenever you can walk away with Profit Day Trading its a good day. 22 Dollars would be next resistance area. With good news this could easily explode. Lots of shorts trying to hold this down. If you look at the Chart its been a rocket ship last couple days. With Support at 20.20 Area and 19 dollar area. This stock loves to dip at Open and then rip afterwards.
